Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer

  • Kim, Do Young (Division of Cardiac Electrophysiology, Korea University Cardiovascular Center, Korea University Guro Hospital) ;
  • Lim, Hong Euy (Division of Cardiac Electrophysiology, Korea University Cardiovascular Center, Korea University Guro Hospital)
  • Received : 2018.03.06
  • Accepted : 2018.03.21
  • Published : 2018.05.31
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol 2014;63:945-53. https://doi.org/10.1016/j.jacc.2013.11.026
  2. Conen D, Wong JA, Sandhu RK, et al. Risk of malignant cancer among women with new-onset atrial fibrillation. JAMA Cardiol 2016;1:389-96. https://doi.org/10.1001/jamacardio.2016.0280
  3. Lee AY, Peterson EA. Treatment of cancer-associated thrombosis. Blood 2013;122:2310-7. https://doi.org/10.1182/blood-2013-04-460162
  4. Lee YJ, Park JK, Uhm JS, et al. Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy. Int J Cardiol 2016;203:372-8. https://doi.org/10.1016/j.ijcard.2015.10.166
  5. Senoo K, Lane D, Lip GY. Stroke and bleeding risk in atrial fibrillation. Korean Circ J 2014;44:281-90. https://doi.org/10.4070/kcj.2014.44.5.281
  6. Kim K, Lee YJ, Kim TH, et al. Effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with newly diagnosed cancer. Korean Circ J 2018;48:406-17. https://doi.org/10.4070/kcj.2017.0328
  7. Short NJ, Connors JM. New oral anticoagulants and the cancer patient. Oncologist 2014;19:82-93. https://doi.org/10.1634/theoncologist.2013-0239
  8. Hendrie PC, Garcia DA. Are new oral anticoagulants ready for use in patients with cancer? J Natl Compr Canc Netw 2013;11:1446-9. https://doi.org/10.6004/jnccn.2013.0165